Latest PEG ratio for PURE Bioscience: -40.15 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-40.15
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
PURE Bioscience (PURE) currently reports a PEG ratio of -40.15. That is below the sector sector average of 3.55. Use the charts on this page to explore PURE Bioscience's PEG ratio history and peer comparisons.
PURE Bioscience's PEG ratio of -40.15 is lower than the its sector sector average of 3.55. That is roughly 1231.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates PURE Bioscience's market price to a fundamental measure such as earnings, sales, or book value. At -40.15, PURE can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -40.15, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 3.55. From there, open related valuation or income-statement pages for PURE Bioscience, and consider following PURE for alerts when major investors trade the stock.